• Personalised medicine
  • TheraGenetics technology
  • Tests in development
  • Portfolio of tests planned

Portfolio of Tests Planned

TheraGenetics portfolio of TheraTests created from our ongoing R&D investment will include response and side effect prediction tests to drug treatments for:

  • Schizophrenia
  • Alzheimer's dementia
  • Depression
  • Bipolar disorder
  • Anxiety disorder
  • ADHD
  • and a range of other CNS disorders...